| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |